Oncologix Tech Inc. (OCLG) Return on Investment ROI from the third quarter of 2015 to third quarter of 2014 and for the year 2015, average high and low, overall ranking from May 31 2015 to May 31 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncologix Tech Inc.  (OCLG)


Oncologix Tech's ROI from its third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oncologix Tech's ROI in the third quarter of 2015?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Oncologix Tech Inc.'s return on investment (ROI) in its third quarter of 2015

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (May 31 2015)
III. Quarter		 (Feb 28 2015)
II. Quarter		 (Nov 30 2014)
I. Quarter		 (Aug 31 2014)
IV. Quarter		 (May 31 2014)
III. Quarter
Y / Y Investment Change TTM - - -63.65 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -1 -1 -1 0 1
Return On Investment (TTM) - - - -423.84 % -379.54 %
OCLG's Overall Ranking # # # # #
Seq. Investment Change TTM - - -86.65 % -24.65 % 47.88 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2 -1 -2 -1 -2

OCLG Company Profile >> Back to OCLG Roi Comparisons >> See Annual OCLG Return On Investment



Return On Investment OCLG's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Oncologix Tech's III. Quarter Investments $ -1 Millions OCLG's Balance sheet
Oncologix Tech's III. Quarter Income $ -1 Millions Quarterly OCLG's Income Statement
OCLG's Income by Division See OCLG's Income by Division


OCLG Annual Return On Investment (Aug 31 2014)
2014		 (Aug 31 2013)
2013		 (Aug 31 2012)
2012

Total Investments in Millions 0 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -1 -1 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -146.09 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OCLG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OCLG's Competitors
Subscribers only: Roi for Oncologix Tech's Suppliers
Subscribers only: Return On Investment for OCLG's Customers

Other Ratios
OCLG's Roa OCLG's Inventory Turnover Ratio OCLG's Growth Rates OCLG's Dividend Statistics
OCLG's Profitability Ratios OCLG's Asset Turnover Ratio OCLG's Dividend Growth
OCLG's Roe OCLG's Valuation Ratios OCLG's Financial Strength Ratios OCLG's Dividend Payout Ratio



Companies with similar Return On Investment at May 31 2015, within Healthcare Sector ROI
Earth Science Tech Inc   556.24 %
Dariohealth Corp   248.29 %
Cba Florida Inc   244.94 %
Adm Tronics Unlimited Inc   239.19 %
Orgenesis Inc   209.50 %
Elite Pharmaceuticals Inc   127.86 %
Armata Pharmaceuticals Inc   95.16 %
Viskase Holdings inc   85.03 %
Proteo Inc  69.41 %

Date modified: 2026-09-08T15:07:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.